|
|
||||||||
1 Microbiology Group, School of Pharmacy, 29–39 Brunswick Square, London WC1N 1AX, UK
2 Bayer Healthcare AG, Pharma Research Center, D-42096 Wuppertal, Germany
3 Mitsui Norin Co. Ltd, 1-2-9 Nishi-Shinbashi, Minato-Ku, Tokyo 105-8427, Japan
Correspondence
Peter W. Taylor
peter.taylor{at}pharmacy.ac.uk
(–)-Epicatechin gallate (ECg), a component of green tea, sensitizes meticillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics, promotes staphylococcal cell aggregation and increases cell-wall thickness. The potentiation of β-lactam activity against MRSA by ECg was not due to decreased bacterial penicillin-binding protein (PBP) 2a expression or ECg binding to peptidoglycan. A 5–10 % reduction in peptidoglycan cross-linking was observed. Reduced cross-linking was insufficient to compromise the integrity of the cell wall and no evidence of PBP2a activity was detected in the muropeptide composition of ECg-grown cells. ECg increased the quantity of autolysins associated with the cell wall, even though the cells were less susceptible to Triton X-100-induced autolysis than cells grown in the absence of ECg. ECg promoted increased lysostaphin resistance that was not due to alteration of the pentaglycine cross-bridge configuration or inhibition of lysostaphin activity. Rather, decreased lysostaphin susceptibility was associated with structural changes to wall teichoic acid (WTA), an acid-labile component of peptidoglycan. ECg also promoted lipoteichoic acid (LTA) release from the cytoplasmic membrane. It is proposed that ECg reduces β-lactam resistance in MRSA either by binding to PBPs at sites distinct from the penicillin-binding site or by intercalation into the cytoplasmic membrane, displacing LTA from the phospholipid palisade. Thus, ECg-mediated alterations to the physical nature of the bilayer will elicit structural changes to WTA that result in modulation of the cell-surface properties necessary to maintain the β-lactam-resistant phenotype.
This article has been cited by other articles:
![]() |
M. Doyle, E.-A. Feuerbaum, K. R. Fox, J. Hinds, D. E. Thurston, and P. W. Taylor Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer J. Antimicrob. Chemother., November 1, 2009; 64(5): 949 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bernal, M. Zloh, and P. W. Taylor Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate J. Antimicrob. Chemother., June 1, 2009; 63(6): 1156 - 1162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |